Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Physicochemical and Biological Stability Assessment of SB11 (Ranibizumab Biosimilar) Under Ambient and In-Use Storage for Intravitreal Administration ; volume:12 ; number:2 ; day:6 ; month:1 ; year:2023 ; pages:985-998 ; date:4.2023
Ophthalmology and therapy ; 12, Heft 2 (6.1.2023), 985-998, 4.2023
- Urheber
-
Kaiser, Peter K.
Yun, Jihoon
Kim, Soyeon
Kim, Jihyun
Park, Su Jin
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40123-022-00645-1
- URN
-
urn:nbn:de:101:1-2408070856385.927302222743
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kaiser, Peter K.
- Yun, Jihoon
- Kim, Soyeon
- Kim, Jihyun
- Park, Su Jin
- SpringerLink (Online service)
Ähnliche Objekte (12)
Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases
Evaluation of the Structural, Physicochemical, and Biological Characteristics of SB11, as Lucentis® (Ranibizumab) Biosimilar
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series
Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
Capsular Block Syndrome after an Intravitreal Injection of Ranibizumab: A Case Report
Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases
Evaluation of the Structural, Physicochemical, and Biological Characteristics of SB11, as Lucentis® (Ranibizumab) Biosimilar
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series
Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema
Capsular Block Syndrome after an Intravitreal Injection of Ranibizumab: A Case Report
Real-World Safety Outcomes of Intravitreal Ranibizumab Biosimilar (Razumab) Therapy for Chorioretinal Diseases
Evaluation of the Structural, Physicochemical, and Biological Characteristics of SB11, as Lucentis® (Ranibizumab) Biosimilar
Intravitreal aflibercept and ranibizumab for pachychoroid neovasculopathy
Comparison Between Ranibizumab Biosimilar, Innovator Ranibizumab and Bevacizumab in a Real-World Situation
Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence
Intravitreal Ranibizumab Injection for the Treatment of Retinopathy of Prematurity
Human Herpesvirus-6 corneal Endotheliitis after intravitreal injection of Ranibizumab
Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study
Intravitreal ranibizumab or conbercept for retinal arterial macroaneurysm: a case series
Short-term effects of intravitreal ranibizumab therapy on diabetic macular edema
Topical bromfenac as adjunctive treatment with intravitreal ranibizumab for diabetic macular edema